Return to homepagePandemic Pact

AfriDx: COVID-19 diagnostics for Africa

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:0 publications

Grant number: RIA2020EF-2918

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $584,921.61

  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)

  • Principal Investigator

    Prof. Elizabeth Hall

  • Research Location

    Senegal, Madagascar
    …

  • Lead Research Institution

    University of Cambridge

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The AfriDx project (RIA2020EF-2918) aims to conduct a trial of a prototype point-of-care LAMP test (PATHPOD) for detection of viral RNA (SARS-Cov-2) in the COVID-19 testing laboratories in Ghana; develop a production process for local manufacture in Ghana of the required biological materials at low cost; produce a version of PATHPOD in Africa for Africa (the AfriDx).